Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
5 "Models, animal"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Basic and Translational Research
Article image
Pancreatic Islet Transplantation in Extrahepatic Sites: Evaluation of the Venous Sac in Large Mammal Models
Giorgi Kenchadze, Ivane Abiatari, Antonello Pileggi, Norma S. Kenyon, Dora M Berman, R. Damaris Molano, Konstantine Gogichaishvili, Revaz Otarashvili, Anzor Tchavtchavadze, Teona Midelashvili, Mariam Motsikulashvili, Camillo Ricordi, Thierry Berney, Ekaterine Berishvili
Diabetes Metab J. 2026;50(3):495-505.   Published online September 8, 2025
DOI: https://doi.org/10.4093/dmj.2024.0400
  • 4,355 View
  • 125 Download
AbstractAbstract PDFPubReader   ePub   
Background
The long-term clinical efficacy of intraportal islet transplantation is hampered by islet loss due to inflammation, oxidative stress, and insufficient vascularization. This study explores the venous sac as an alternative implantation site for islet transplantation in large animal models.
Methods
An immunosuppressed, diabetic cynomolgus monkey received allogeneic islet implants in its mesenteric venous sac, with metabolic assessments over 112 days. Dogs underwent islet autotransplantation into various venous sacs, with their glycemic control and other metabolic parameters monitored for 1 month.
Results
In a nonhuman primate, the mesenteric venous sac site improved glycemic control over a 3-month period, followed by destabilization of graft function. Histological studies revealed healthy islets. The lack of mononuclear cell infiltrate suggested no signs of graft rejection. Saphenous venous sacs in dogs showed superior glycemic control, reduced insulin requirements, and maintained C-peptide levels, comparable to intraportal transplantation. Histological analyses confirmed islet preservation and graft vascularization in saphenous venous sacs.
Conclusion
This study provides preclinical evidence in support of the venous sac as a valuable extrahepatic location for pancreatic islet implantation. We found that the saphenous vein is a more effective site for islet engraftment than the mesenteric vein. This study offers potential benefits for improving the success rates of clinical islet transplantation.
Reviews
Complications
Peripheral Neuropathy Phenotyping in Rat Models of Type 2 Diabetes Mellitus: Evaluating Uptake of the Neurodiab Guidelines and Identifying Future Directions
Md Jakir Hossain, Michael D. Kendig, Meg E. Letton, Margaret J. Morris, Ria Arnold
Diabetes Metab J. 2022;46(2):198-221.   Published online March 24, 2022
DOI: https://doi.org/10.4093/dmj.2021.0347
  • 17,061 View
  • 376 Download
  • 23 Web of Science
  • 25 Crossref
AbstractAbstract PDFPubReader   ePub   
Diabetic peripheral neuropathy (DPN) affects over half of type 2 diabetes mellitus (T2DM) patients, with an urgent need for effective pharmacotherapies. While many rat and mouse models of T2DM exist, the phenotyping of DPN has been challenging with inconsistencies across laboratories. To better characterize DPN in rodents, a consensus guideline was published in 2014 to accelerate the translation of preclinical findings. Here we review DPN phenotyping in rat models of T2DM against the ‘Neurodiab’ criteria to identify uptake of the guidelines and discuss how DPN phenotypes differ between models and according to diabetes duration and sex. A search of PubMed, Scopus and Web of Science databases identified 125 studies, categorised as either diet and/or chemically induced models or transgenic/spontaneous models of T2DM. The use of diet and chemically induced T2DM models has exceeded that of transgenic models in recent years, and the introduction of the Neurodiab guidelines has not appreciably increased the number of studies assessing all key DPN endpoints. Combined high-fat diet and low dose streptozotocin rat models are the most frequently used and well characterised. Overall, we recommend adherence to Neurodiab guidelines for creating better animal models of DPN to accelerate translation and drug development.

Citations

Citations to this article as recorded by  
  • Immunological mechanisms and therapeutic advances in diabetic neuropathy
    Suli Jiang, Linxiang Zhang, Lizhen Zhao, Yuchen Lv, Shaoyun Cheng, Cun Liu, Shengwei Xu, Bei Zhang
    Journal of Neurology.2026;[Epub]     CrossRef
  • Metabolic and biochemical profiling reveals phenotypic heterogeneity in Zucker diabetic fatty rats
    Marek Lepáček, Pavol Boďo, Barbora Kaločayová, Marta Šoltésová Prnová
    Animal Models and Experimental Medicine.2026; 9(3): 442.     CrossRef
  • Iridoids from Traditional Chinese Medicine for Neuropathic Pain: Therapeutic Potential and Molecular Mechanisms
    Wenjun Wang, Tianlong Liu, Yi Ding, Xiaolong Liu, Ren Qingji, Yi Zhang, Zhengxiang Zhang
    Drug Design, Development and Therapy.2026; Volume 20: 1.     CrossRef
  • Effects of Sitagliptin and Celery Seed Extract on Corneal Nerve Morphology and Sensory Dysfunction in Diabetic Rats
    Samea Khan, Maria Markoulli, Lamia Nureen, Nick Di Girolamo, Mark Willcox
    Nutrients.2026; 18(14): 2243.     CrossRef
  • Mechanistic Insights into Diabetic Neuropathy: Oxidative Stress, Mitochondrial Injury, and Translational Therapeutics
    Muzafar Ahmad Mir, Showkat ul Nabi, Rakeeb Ahmad Mir, Sofi Imtiyaz Ali, Irfan Ahmed Noorani, Shabista Muzaffar, Ibraq Khurshid
    SN Comprehensive Clinical Medicine.2026;[Epub]     CrossRef
  • Following changes in brain structure and function with multimodal MRI in a year-long prospective study on the development of Type 2 diabetes
    Yingjie Wang, Richard Ortiz, Arnold Chang, Taufiq Nasseef, Natalia Rubalcaba, Chandler Munson, Ashley Ghaw, Shreyas Balaji, Yeani Kwon, Deepti Athreya, Shruti Kedharnath, Praveen P. Kulkarni, Craig F. Ferris
    Frontiers in Radiology.2025;[Epub]     CrossRef
  • Rodent Models of Diabetic Neuropathy, Role of Calcium Homeostasis in Pain and KB-R7943 as a Potential Therapeutic
    Natasha Ivanova, Milen Hristov, Pavlina Gateva
    International Journal of Molecular Sciences.2025; 26(5): 2094.     CrossRef
  • Novel three-dimensional analysis method for accurate evaluation of cutaneous small sensory nerve fibers in mice
    Minori Inanaga- Kojima, Tetsuro Matsuura, Kiyokazu Ozaki
    Journal of Toxicologic Pathology.2025; 38(2): 167.     CrossRef
  • Dapagliflozin Ameliorate Type-2 Diabetes Associated Neuropathy via Regulation of IGF-1R Signaling
    Prabhsimran Kaur, Tashvinder Singh, Laxmipriya Jena, Tanya Gupta, Manjit Kaur Rana, Sandeep Singh, Randhir Singh, Puneet Kumar, Anjana Munshi
    Journal of Neuroimmune Pharmacology.2025;[Epub]     CrossRef
  • Ameliorating Effect of Red Fruit (Pandanus conoides Lamk) Oil in Streptozotosin-Induced Diabetic Peripheral Neuropathy Rat Model: role of oxidative and neuroinflammatory pathways
    Indah Tri Lestari, Kusnandar Anggadiredja, Afrillia Nuryanti Garmana, Ratna Annisa Utami
    Journal of Pharmacopuncture.2025; 28(1): 11.     CrossRef
  • Alpha-Tocopherol-Loaded Liposomes Reduce High Glucose Induced Oxidative Stress in Schwann Cells: A Proof of Concept Study
    Jee-In Heo, Mi Jeong Kim, Daehyun Kim, Jimin Seo, Joon Ho Moon, Sung Hee Choi, Hak Jong Lee, Tae Jung Oh
    Diabetes & Metabolism Journal.2025; 49(3): 507.     CrossRef
  • Exploring the efficacy of plant-based nutraceuticals in managing diabetic neuropathy
    Samea Khan, Maria Markoulli, Amy T. Tsoi, Mark Willcox
    Inflammopharmacology.2025; 33(6): 2935.     CrossRef
  • Cell-derived exosome therapy for diabetic peripheral neuropathy: a preclinical animal studies systematic review and meta-analysis
    Xianying Lu, Ran Xu, Xiaohui Dong, Dingxi Bai, Wenting Ji, Xinyu Chen, Huan Chen, Chaoming Hou, Jing Gao
    Stem Cell Research & Therapy.2025;[Epub]     CrossRef
  • Antinociceptive effects of ursolic acid in rats with diabetic peripheral neuropathy: Behavioral, biochemical, and molecular docking evidence
    Varsha Motilal Shende, Deepti Dinesh Bandawane
    Pharmacological Research - Natural Products.2025; 8: 100305.     CrossRef
  • Diabetic peripheral neuropathy: Role of nitric oxide
    Zahra Bahadoran, Asghar Ghasemi
    Nitric Oxide.2025; 159: 147.     CrossRef
  • Chitosan Protects Peripheral Nerves Against Damage Induced by Diabetes Mellitus
    Anca-Maria Țucă, Carmen Albu, Alexandra Nicoleta Preda, Alexandra Oltea Dan, Elena-Anca Târtea, Andrei Greșiță, Denisa Floriana Vasilica Pîrșcoveanu, Veronica Sfredel, Smaranda Ioana Mitran, Georgică Târtea
    Life.2025; 15(12): 1860.     CrossRef
  • Differential affective behavioral outcomes in streptozotocin-induced diabetic mice: implications for pain-depression comorbidity research
    Ryun-Seong Kim, Ji-Hee Yeo, Hoon-Seong Choi, Seo-Yeon Yoon, Dae-Hyun Roh
    International Journal of Oral Biology.2025; 50(4): 179.     CrossRef
  • SIRT3 alleviates painful diabetic neuropathy by mediating the FoxO3a‐PINK1‐Parkin signaling pathway to activate mitophagy
    Jing Yang, Zhuoying Yu, Ye Jiang, Zixian Zhang, Yue Tian, Jie Cai, Min Wei, Yanhan Lyu, Dongsheng Yang, Shixiong Shen, Guo‐Gang Xing, Min Li
    CNS Neuroscience & Therapeutics.2024;[Epub]     CrossRef
  • Long-term sensorimotor changes after a sciatic nerve block with bupivacaine and liposomal bupivacaine in a high-fat diet/low-dose streptozotocin rodent model of diabetes
    Susanna C. Byram, Krista M. Lotesto, Michael Volyanyuk, Jacob E. Exline, Elizabeth A. Sager, Eileen M. Foecking
    Frontiers in Anesthesiology.2024;[Epub]     CrossRef
  • The impact of gut microbial dysbiosis on the atrophy of the hippocampus and abnormal metabolism of N-acetyl aspartate in type 2 diabetic rats
    Zhenyang Zhu, Qingqing Chen, Gege Jiang, Yuan Liang, Jing Shen, Jianlin Wu
    Heliyon.2024; 10(12): e33152.     CrossRef
  • Advances in the treatment of diabetic peripheral neuropathy by modulating gut microbiota with traditional Chinese medicine
    Ye-Yao Li, Rui-Qian Guan, Zhi-Bo Hong, Yao-Lei Wang, Li-Min Pan
    World Journal of Diabetes.2024; 15(8): 1712.     CrossRef
  • Painful Diabetic Neuropathy: Sex-Specific Mechanisms and Differences from Animal Models to Clinical Outcomes
    Emma Merlin, Chiara Salio, Francesco Ferrini
    Cells.2024; 13(23): 2024.     CrossRef
  • Compound Qiying Granules alleviates diabetic peripheral neuropathy by inhibiting endoplasmic reticulum stress and apoptosis
    Yan Hu, Chen Chen, Zhengting Liang, Tao Liu, Xiaoling Hu, Guanying Wang, Jinxia Hu, Xiaolin Xie, Zhiyan Liu
    Molecular Medicine.2023;[Epub]     CrossRef
  • HCV affects KATP channels through GnT-IVa-mediated N-glycosylation of GLUT2 on the surface of pancreatic β-cells leading to impaired insulin secretion
    Ben Niu, Lijing Ma, Lixuan Yao, Yating Zhang, Heng Su
    Endocrine.2023; 84(2): 427.     CrossRef
  • Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats
    Annalisa Canta, Valentina A. Carozzi, Alessia Chiorazzi, Cristina Meregalli, Norberto Oggioni, Virginia Rodriguez-Menendez, Barbara Sala, Roberto Cosimo Melcangi, Silvia Giatti, Raffaella Lombardi, Roberto Bianchi, Paola Marmiroli, Guido Cavaletti
    Biomedicines.2022; 11(1): 20.     CrossRef
Basic Research
Article image
Application of Animal Models in Diabetic Cardiomyopathy
Wang-Soo Lee, Jaetaek Kim
Diabetes Metab J. 2021;45(2):129-145.   Published online March 25, 2021
DOI: https://doi.org/10.4093/dmj.2020.0285
  • 20,156 View
  • 451 Download
  • 25 Web of Science
  • 28 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFPubReader   ePub   
Diabetic heart disease is a growing and important public health risk. Apart from the risk of coronary artery disease or hypertension, diabetes mellitus (DM) is a well-known risk factor for heart failure in the form of diabetic cardiomyopathy (DiaCM). Currently, DiaCM is defined as myocardial dysfunction in patients with DM in the absence of coronary artery disease and hypertension. The underlying pathomechanism of DiaCM is partially understood, but accumulating evidence suggests that metabolic derangements, oxidative stress, increased myocardial fibrosis and hypertrophy, inflammation, enhanced apoptosis, impaired intracellular calcium handling, activation of the renin-angiotensin-aldosterone system, mitochondrial dysfunction, and dysregulation of microRNAs, among other factors, are involved. Numerous animal models have been used to investigate the pathomechanisms of DiaCM. Despite some limitations, animal models for DiaCM have greatly advanced our understanding of pathomechanisms and have helped in the development of successful disease management strategies. In this review, we summarize the current pathomechanisms of DiaCM and provide animal models for DiaCM according to its pathomechanisms, which may contribute to broadening our understanding of the underlying mechanisms and facilitating the identification of possible new therapeutic targets.

Citations

Citations to this article as recorded by  
  • Insights into INS Gene Variation from Seven Years of Monogenic Diabetes Testing—Novel Genetic Variants and Their Clinical Implications
    Tomasz Płoszaj, Patrycja Mojsak, Sebastian Skoczylas, Katarzyna Piekarska, Maciej Borowiec, Barbara Salmonowicz, Leszek Czupryniak, Małgorzata Mysliwiec, János András Mótyán, Krisztina Tar, Agnieszka Zmysłowska
    Applied Sciences.2026; 16(2): 795.     CrossRef
  • Investigating the biomarkers of diabetic-cardiomyopathy with the high mobility group box-1 as a potential anti-inflammatory therapeutic target: Systematic Review and meta-analysis
    Ranmali Ranasinghe, Michael Mathai, Anthony Zulli
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Transcriptional regulatory network analysis uncovers modular gene control and potential key regulators in diabetic cardiomyopathy
    Fernanda Fredericksen, Víctor Aliaga-Tobar, Sebastián Aedo-Cares, Jorge Torres, Sebastián Leiva-Navarrete, Darío Parra-Cofré, Daniel Uribe, Ángel Raya, Alex Di Genova, Rodrigo Troncoso, Valentina Parra, Mauricio Latorre
    Frontiers in Cell and Developmental Biology.2026;[Epub]     CrossRef
  • Modulation of the gut-heart axis by exercise in diabetic cardiomyopathy: Microbial mechanisms and clinical implications
    Jun Chen, Zhiwei Fan, Yuan Li, Rui Duan, Binghong Gao
    iScience.2026; 29(4): 115490.     CrossRef
  • Tongmai Hypoglycemic Capsule Attenuates Myocardial Oxidative Stress and Fibrosis in the Development of Diabetic Cardiomyopathy in Rats
    Jie-qiong Zeng, Hui-fen Zhou, Hai-xia Du, Yu-jia Wu, Qian-ping Mao, Jun-jun Yin, Hai-tong Wan, Jie-hong Yang
    Chinese Journal of Integrative Medicine.2025; 31(3): 251.     CrossRef
  • Mechanistic insight into the role of cardiac-enriched microRNAs in diabetic heart injury
    Branislav Kura, Lucia Kindernay, Dinender Singla, Ulrika Dulova, Monika Bartekova
    American Journal of Physiology-Heart and Circulatory Physiology.2025; 328(4): H865.     CrossRef
  • Pulmonary effects of waterpipe generated smoke in adult diabetic rats
    Rima Kamel, Sibelle Kassouf, Selim M. Nasser, Amale Mcheik, Nathalie Hayeck, Elias Abi-Ramia, Hanan ElKazzaz, Christian Khalil, Aniella Abi-Gerges
    Toxicology and Applied Pharmacology.2025; 499: 117319.     CrossRef
  • Ranolazine as a therapeutic agent for diabetic cardiomyopathy: reducing endoplasmic reticulum stress and inflammation in type 2 diabetic rat model
    Matin Mohyadini, Aghele Fahimi, S. Zahra Bathaie, Hamid Yaghooti
    BMC Pharmacology and Toxicology.2025;[Epub]     CrossRef
  • Interaction between mitochondrial oxidative stress and myocardial fibrosis in the context of diabetes
    Pu-Hua Zhang, Nuo-Nan Li, Xiang Gu, Chun-Xia Zhou, Zhen-Zhen Jiang, Xian-Jun Luo, Hong-Wen Zhu, Xiao-Yong Zhu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • High-Fat Diet-Induced Diabetic Cardiomyopathy in Female Zebrafish: Cardiac Pathology and Functional Decline Mediated by Type 2 Diabetes
    Shuaiwang Huang, Zhanglin Chen, Haoming Li, Yunyi Zou, Bihan Wang, Wenjun Zhao, Lan Zheng, Zuoqiong Zhou, Xiyang Peng, Changfa Tang
    Nutrients.2025; 17(13): 2209.     CrossRef
  • Cross-regulation of methylation and oxidative stress: molecular mechanisms and intervention strategies of diabetic cardiomyopathy
    Ya-qi Guo, Jia-yin Zhang, Pan-pan Hou, Chen-xi Jia, Tian-lu Zhu, Qi-rui Zhang, Zheng-wei Du, Dan-jie Li, Yu-ting Xi, Qian-qian Niu, Peng Li
    European Journal of Pharmacology.2025; 1005: 178080.     CrossRef
  • Chitosan Versus Dapagliflozin in a Diabetic Cardiomyopathy Mouse Model
    Georgică Târtea, Aurel Popa-Wagner, Veronica Sfredel, Smaranda Ioana Mitran, Alexandra Oltea Dan, Anca-Maria Țucă, Alexandra Nicoleta Preda, Victor Raicea, Eugen Țieranu, Dragoș Cozma, Radu Vătășescu
    International Journal of Molecular Sciences.2024; 25(4): 2118.     CrossRef
  • Mitochondrial energy metabolism in diabetic cardiomyopathy: Physiological adaption, pathogenesis, and therapeutic targets
    Wanlin Ye, Kun Han, Maodi Xie, Sheyu Li, Guo Chen, Yanyan Wang, Tao Li
    Chinese Medical Journal.2024; 137(8): 936.     CrossRef
  • Liraglutide Attenuates Diabetic Cardiomyopathy via the ILK/PI3K/AKT/PTEN Signaling Pathway in Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus
    Shatha M. Alobaid, Rahaf M. Alshahrani, Asma S. Alonazi, Nawal M. Alrasheed, Maha A. Alamin, Tahani K. Alshammari, Anfal F. Bin Dayel, Doaa M. Elnagar, Rana R. Alotaibi, Lama A. Almuthnabi, Dalia H. Almasud, Shahad E. Al-Ammar, Shahad O. Almadhi, Reema A.
    Pharmaceuticals.2024; 17(3): 374.     CrossRef
  • An Overview of Diabetic Cardiomyopathy
    Abdul Quaiyoom, Ranjeet Kumar
    Current Diabetes Reviews.2024;[Epub]     CrossRef
  • Progress in experimental models to investigate the in vivo and in vitro antidiabetic activity of drugs
    Yasodha Krishna Janapati, Sunil Junapudi
    Animal Models and Experimental Medicine.2024; 7(3): 297.     CrossRef
  • The role of NF-κB in diabetic cardiomyopathy
    Huang-Jun Liu, Le-Kun Gui, Han Wei, Xing-Yu Zhou, Zhen-Lan Liu, Li-Jun Jin
    All Life.2024;[Epub]     CrossRef
  • A reliable strategy for establishment of an animal model of diabetic cardiomyopathy: Induction by a high-fat diet combined with single or multiple injections of low-dose streptozotocin
    Weixing Wen, Yue Cao, Peng Chen, Jiahuan Li, Weiwen Li, Guolin Huang, Haoxiao Zheng, Xiaolin Zhu, Hao Zhang, Yangxin Chen, Xiaohui Huang, Yunzhao Hu, Yuli Huang
    Life Sciences.2024; 358: 123161.     CrossRef
  • Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
    Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon
    International Journal of Heart Failure.2023; 5(1): 1.     CrossRef
  • Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
    Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon
    Diabetes & Metabolism Journal.2023; 47(1): 10.     CrossRef
  • Machine learning for spatial stratification of progressive cardiovascular dysfunction in a murine model of type 2 diabetes mellitus
    Andrya J. Durr, Anna S. Korol, Quincy A. Hathaway, Amina Kunovac, Andrew D. Taylor, Saira Rizwan, Mark V. Pinti, John M. Hollander, Yoshihiro Fukumoto
    PLOS ONE.2023; 18(5): e0285512.     CrossRef
  • Hyperglycemic memory in diabetic cardiomyopathy
    Jiabing Zhan, Chen Chen, Dao Wen Wang, Huaping Li
    Frontiers of Medicine.2022; 16(1): 25.     CrossRef
  • Murine Models of Obesity
    Tânia Martins, Catarina Castro-Ribeiro, Sílvia Lemos, Tiago Ferreira, Elisabete Nascimento-Gonçalves, Eduardo Rosa, Paula Alexandra Oliveira, Luís Miguel Antunes
    Obesities.2022; 2(2): 127.     CrossRef
  • The Role of Mitochondria in Metabolic Syndrome–Associated Cardiomyopathy
    Jiayu Li, Jingye Li, Yijun Chen, Wenyu Hu, Xuhe Gong, Hui Qiu, Hui Chen, Yanguo Xin, Hongwei Li, Tao Li
    Oxidative Medicine and Cellular Longevity.2022;[Epub]     CrossRef
  • Guidelines on models of diabetic heart disease
    Lisa C. Heather, Anne D. Hafstad, Ganesh V. Halade, Romain Harmancey, Kimberley M. Mellor, Paras K. Mishra, Erin E. Mulvihill, Miranda Nabben, Michinari Nakamura, Oliver J. Rider, Matthieu Ruiz, Adam R. Wende, John R. Ussher
    American Journal of Physiology-Heart and Circulatory Physiology.2022; 323(1): H176.     CrossRef
  • Extracellular vesicle therapy for non-ischemic heart failure: A systematic review of preclinical studies
    Ramana Vaka, Sophie Van Remortel, Valentina Ly, Darryl R. Davis
    Extracellular Vesicle.2022; 1: 100009.     CrossRef
  • Effect of a Six-week Endurance Exercise Program and Empagliflozin Consumption on Some Structural and Functional Indices of the Heart in Male Diabetic Rats
    Eftekhar Mohammadi, Mohammad Fathi, Farzaneh Chehel Cheraghi, Afshin Nazari
    journal of ilam university of medical sciences.2022; 30(3): 1.     CrossRef
  • Cardiac Phosphodiesterases Are Differentially Increased in Diabetic Cardiomyopathy
    Rita Hanna, Wared Nour-Eldine, Youakim Saliba, Carole Dagher-Hamalian, Pia Hachem, Pamela Abou-Khalil, Delphine Mika, Audrey Varin, Magali Samia El Hayek, Laëtitia Pereira, Nassim Farès, Grégoire Vandecasteele, Aniella Abi-Gerges
    Life Sciences.2021; 283: 119857.     CrossRef
Complications
Article image
Lost in Translation? Measuring Diabetic Neuropathy in Humans and Animals
Heung Yong Jin, Seong-Su Moon, Nigel A. Calcutt
Diabetes Metab J. 2021;45(1):27-42.   Published online December 15, 2020
DOI: https://doi.org/10.4093/dmj.2020.0216
  • 17,969 View
  • 296 Download
  • 18 Web of Science
  • 19 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFPubReader   ePub   
The worldwide diabetes epidemic is estimated to currently afflict almost 500 million persons. Long-term diabetes damages multiple organ systems with the blood vessels, eyes, kidneys and nervous systems being particularly vulnerable. These complications of diabetes reduce lifespan, impede quality of life and impose a huge social and economic burden on both the individual and society. Peripheral neuropathy is a debilitating complication that will impact over half of all persons with diabetes. There is no treatment for diabetic neuropathy and a disturbingly long history of therapeutic approaches showing promise in preclinical studies but failing to translate to the clinic. These failures have prompted re-examination of both the animal models and clinical trial design. This review focuses on the functional and structural parameters used as indices of peripheral neuropathy in preclinical and clinical studies and the extent to which they share a common pathogenesis and presentation. Nerve conduction studies in large myelinated fibers have long been the mainstay of preclinical efficacy screening programs and clinical trials, supplemented by quantitative sensory tests. However, a more refined approach is emerging that incorporates measures of small fiber density in the skin and cornea alongside these traditional assays at both preclinical and clinical phases.

Citations

Citations to this article as recorded by  
  • Mouse Models of Diabetic Complications: Dissecting Molecular Mechanisms of Disease Progression
    Aejin Lee
    Frontiers in Bioscience-Landmark.2026;[Epub]     CrossRef
  • Mechanistic Insights into Diabetic Neuropathy: Oxidative Stress, Mitochondrial Injury, and Translational Therapeutics
    Muzafar Ahmad Mir, Showkat ul Nabi, Rakeeb Ahmad Mir, Sofi Imtiyaz Ali, Irfan Ahmed Noorani, Shabista Muzaffar, Ibraq Khurshid
    SN Comprehensive Clinical Medicine.2026;[Epub]     CrossRef
  • Ways of measuring peripheral neuropathy severity and its association with retinopathy in patients with diabetes: A scoping review protocol
    Aristomenis Kossioris, Stylianos Kandarakis, Spyridon Doumazos, Petros Petrou
    F1000Research.2025; 14: 66.     CrossRef
  • Association of peripheral neuropathy with dementia in type 2 diabetes: a 5-year follow-up study using the national health insurance service-national health information database
    Heung Yong Jin, Ko Woon Kim, Kyung Ae Lee, Tae Sun Park, Min Ji Kim, Jong Seung Kim
    Endocrine.2025; 89(2): 456.     CrossRef
  • Cognitive Dysfunction and Dementia in Type 2 Diabetes Mellitus: Insights into Mechanisms, Models, and Therapeutics
    Junhong Zeng, Keer Hu, Zitian Wang, Yi-chun Huang, Yu Zhang, Haiying Peng, Shaohua Ma
    ACS Pharmacology & Translational Science.2025; 8(8): 2337.     CrossRef
  • Cardioprotective Effect of Capsaicin Against Myocardial Ischemia–Reperfusion Injury in a Diabetic Rat Model via Activation of the TRPV1-CGRP Pathway
    Tu-Ping Li, Zhen Liu, Yi Han, Tao Sun, Yi Lei, Lin-Zhong Zhang
    Bratislava Medical Journal.2025; 126(10): 2604.     CrossRef
  • Painful Diabetic Neuropathy: Sex-Specific Mechanisms and Differences from Animal Models to Clinical Outcomes
    Emma Merlin, Chiara Salio, Francesco Ferrini
    Cells.2024; 13(23): 2024.     CrossRef
  • Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options
    Raffaele Galiero, Alfredo Caturano, Erica Vetrano, Domenico Beccia, Chiara Brin, Maria Alfano, Jessica Di Salvo, Raffaella Epifani, Alessia Piacevole, Giuseppina Tagliaferri, Maria Rocco, Ilaria Iadicicco, Giovanni Docimo, Luca Rinaldi, Celestino Sardu, T
    International Journal of Molecular Sciences.2023; 24(4): 3554.     CrossRef
  • Bidirectional association between diabetic peripheral neuropathy and vitamin B12 deficiency: Two longitudinal 9-year follow-up studies using a national sample cohort
    Heung Yong Jin, Kyung Ae Lee, Yu Ji Kim, In Sun Gwak, Tae Sun Park, Sang Woo Yeom, Jong Seung Kim
    Primary Care Diabetes.2023; 17(5): 436.     CrossRef
  • Advanced Drug Delivery System for Management of Chronic Diabetes Wound Healing
    Harish Bhardwaj, Sulekha Khute, Ram Sahu, Rajendra Kumar Jangde
    Current Drug Targets.2023; 24(16): 1239.     CrossRef
  • A Real-World Analysis of High-Frequency 10 kHz Spinal Cord Stimulation for the Treatment of Painful Diabetic Peripheral Neuropathy
    Jeffrey L. Chen, Andrew W. Hesseltine, Sara E. Nashi, Shawn M. Sills, Tory L. McJunkin, Sandeep Patil, Manish Bharara, David L. Caraway, Elizabeth S. Brooks
    Journal of Diabetes Science and Technology.2022; 16(2): 282.     CrossRef
  • Using Corneal Confocal Microscopy to Identify Therapeutic Agents for Diabetic Neuropathy
    Corinne G. Jolivalt, May Madi Han, Annee Nguyen, Fiona Desmond, Carlos Henrique Alves Jesus, Daniela C. Vasconselos, Andrea Pedneault, Natalie Sandlin, Sage Dunne-Cerami, Katie E. Frizzi, Nigel A. Calcutt
    Journal of Clinical Medicine.2022; 11(9): 2307.     CrossRef
  • Glycyrrhizic acid promotes sciatic nerves recovery in type 1 diabetic rats and protects Schwann cells from high glucose-induced cytotoxicity
    Min Shi, Xiangcheng Zhang, Ridong Zhang, Hong Zhang, Dalong Zhu, Xiao Han
    The Journal of Biomedical Research.2022; 36(3): 181.     CrossRef
  • Novel mechanisms of pain in painful diabetic neuropathy
    Rayaz A. Malik
    Nature Reviews Endocrinology.2022; 18(8): 459.     CrossRef
  • An induced pluripotent stem cell-based model identifies molecular targets of vincristine neurotoxicity
    Neng-Wei Tsai, Cheng-Chen Lin, Ti-Yen Yeh, Yu-An Chiu, Hsin-Hui Chiu, Hsiang-Po Huang, Sung-Tsang Hsieh
    Disease Models & Mechanisms.2022;[Epub]     CrossRef
  • Corneal Confocal Microscopy: A Biomarker for Diabetic Peripheral Neuropathy
    Ioannis N. Petropoulos, Georgios Ponirakis, Maryam Ferdousi, Shazli Azmi, Alise Kalteniece, Adnan Khan, Hoda Gad, Bilal Bashir, Andrew Marshall, Andrew J.M. Boulton, Handrean Soran, Rayaz A. Malik
    Clinical Therapeutics.2021; 43(9): 1457.     CrossRef
  • Lost in Translation? Measuring Diabetic Neuropathy in Humans and Animals (Diabetes Metab J 2021;45:27-42)
    Otto Jesus Hernandez Fustes
    Diabetes & Metabolism Journal.2021; 45(3): 452.     CrossRef
  • Lost in Translation? Measuring Diabetic Neuropathy in Humans and Animals (Diabetes Metab J 2021;45:27-42)
    Heung Yong Jin, Seong-Su Moon, Nigel A. Calcutt
    Diabetes & Metabolism Journal.2021; 45(3): 457.     CrossRef
  • Sterculia tragacantha Lindl Leaf Extract Ameliorates STZ-Induced Diabetes, Oxidative Stress, Inflammation and Neuronal Impairment
    Amos Sunday Onikanni, Bashir Lawal, Augustine O Olusola, Janet O Olugbodi, Saidu Sani, Basiru Olaitan Ajiboye, Omotayo B Ilesanmi, Mohammed Alqarni, Gomaa Mostafa-Hedeab, Ahmad J Obaidullah, Gaber El-Saber Batiha, Alexander TH Wu
    Journal of Inflammation Research.2021; Volume 14: 6749.     CrossRef
Original Article
Pattern of Stress-Induced Hyperglycemia according to Type of Diabetes: A Predator Stress Model
Jin-Sun Chang, Young-Hye You, Shin-Young Park, Ji-Won Kim, Hun-Sung Kim, Kun-Ho Yoon, Jae-Hyoung Cho
Diabetes Metab J. 2013;37(6):475-483.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.475
  • 12,397 View
  • 92 Download
  • 6 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

We aimed to quantify stress-induced hyperglycemia and differentiate the glucose response between normal animals and those with diabetes. We also examined the pattern in glucose fluctuation induced by stress according to type of diabetes.

Methods

To load psychological stress on animal models, we used a predator stress model by exposing rats to a cat for 60 minutes and measured glucose level from the beginning to the end of the test to monitor glucose fluctuation. We induced type 1 diabetes model (T1D) for ten Sprague-Dawley rats using streptozotocin and used five Otsuka Long-Evans Tokushima Fatty rats as obese type 2 diabetes model (OT2D) and 10 Goto-Kakizaki rats as nonobese type 2 diabetes model (NOT2D). We performed the stress loading test in both the normal and diabetic states and compared patterns of glucose fluctuation among the three models. We classified the pattern of glucose fluctuation into A, B, and C types according to speed of change in glucose level.

Results

Increase in glucose, total amount of hyperglycemic exposure, time of stress-induced hyperglycemia, and speed of glucose increase were significantly increased in all models compared to the normal state. While the early increase in glucose after exposure to stress was higher in T1D and NOT2D, it was slower in OT2D. The rate of speed of the decrease in glucose level was highest in NOT2D and lowest in OT2D.

Conclusion

The diabetic state was more vulnerable to stress compared to the normal state in all models, and the pattern of glucose fluctuation differed among the three types of diabetes. The study provides basic evidence for stress-induced hyperglycemia patterns and characteristics used for the management of diabetes patients.

Citations

Citations to this article as recorded by  
  • Endothelial function can be modulated by acute hyperglycemia
    Hassanain Qambari, Paula K. Yu, Chandrakumar Balaratnasingam, Jayden Dickson, Dao-Yi Yu
    Scientific Reports.2025;[Epub]     CrossRef
  • Stress hyperglycemia as first sign of asymptomatic type 1 diabetes: an instructive case
    Wei-De Wang, Chun-Hao Chu, Chiung-Hsi Tien, Shuo-Yu Wang, Shih-Yao Liu, Chien-Ming Lin
    BMC Pediatrics.2021;[Epub]     CrossRef
  • Genetic determinants of obesity heterogeneity in type II diabetes
    Somayeh Alsadat Hosseini Khorami, Mohd Sokhini Abd Mutalib, Mohammad Feili Shiraz, Joseph Anthony Abdullah, Zulida Rejali, Razana Mohd Ali, Huzwah Khaza’ai
    Nutrition & Metabolism.2020;[Epub]     CrossRef
  • Sex Dimorphic Responses of the Hypothalamus–Pituitary–Thyroid Axis to Maternal Separation and Palatable Diet
    Lorraine Jaimes-Hoy, Fidelia Romero, Jean-Louis Charli, Patricia Joseph-Bravo
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Hesperidin protects against stress induced gastric ulcer through regulation of peroxisome proliferator activator receptor gamma in diabetic rats
    Shimaa M. Elshazly, Dalia M. Abd El Motteleb, Islam A.A.E-H. Ibrahim
    Chemico-Biological Interactions.2018; 291: 153.     CrossRef
  • Physiology and Neurobiology of Stress and the Implications for Physical Health
    B Sivaprakash
    Annals of SBV.2014; 3(1): 25.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP